COMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's ...
CAMBRIDGE, MA / ACCESS Newswire / April 21, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in ...
April 21 (Reuters) - Moderna said on Tuesday the European Commission had approved its combination vaccine for the prevention ...
Moderna (NasdaqGS:MRNA) plans to present Phase 1/2 data for its mRNA-4359 cancer antigen therapy combined with pembrolizumab ...
US biotech Moderna today announced that the European Commission (EC) has granted marketing authorization for mCOMBRIAX ...
Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a ...
Amid its battles with the U.S. Food and Drug Administration, Moderna Inc. has landed an important approval in Europe.
Moderna MRNA shares are moving higher on Monday after the company won FDA Fast Track status for an oncology program, helping ...
Moderna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses ...
5d
What Moderna (MRNA)'s Expedited Flu Vaccine Review And Institutional Support Means For Shareholders
Moderna, Inc. recently participated in the 5th LNP Formulation & Process Development Summit in Boston and scheduled a May 1, ...
The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results